| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Relay Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 136,681 | 06 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RLAY | Relay Therapeutics, Inc. | 06 Jun 2025 | 1 | $0 | 4 | Director | 06 Jun 2025, 17:51 |
| RLAY | Relay Therapeutics, Inc. | 03 Jun 2024 | 1 | $0 | 4 | Director | 05 Jun 2024, 20:05 |
| RLAY | Relay Therapeutics, Inc. | 31 May 2023 | 1 | $0 | 4 | Director | 01 Jun 2023, 18:37 |
| RLAY | Relay Therapeutics, Inc. | 08 Sep 2022 | 1 | -$748,750 | 4 | Director | 08 Sep 2022, 20:31 |
| RLAY | Relay Therapeutics, Inc. | 27 May 2022 | 1 | $0 | 4 | Director | 27 May 2022, 17:41 |
| RLAY | Relay Therapeutics, Inc. | 19 May 2021 | 1 | $0 | 4 | Director | 21 May 2021, 19:44 |